Jci_page_head_homepage_01 Jci_page_head_homepage_02
Elizabeth J. Parks, Ronald M. Krauss, Mark P. Christiansen, Richard A. Neese, Marc K. Hellerstein
Published in Volume 104, Issue 8
J Clin Invest. 1999; 104(8):1087–1096 doi:10.1172/JCI6572
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

Percentage of VLDL-TG palmitate derived from the plasma NEFA pool. Data are from 2 representative subjects on the control diet: an NL subject (top) and an HTG subject (bottom). The infusion of [1,2,3,4-13C4]palmitate (from 0400 to 1600 hours) reached steady state within the plasma NFA pool 1 hour after the start of the infusion.